期刊文献+

外排泵抑制剂对铜绿假单胞菌碳青霉烯类抗菌药物敏感性的影响 被引量:12

Effects of efflux pump inhibitors on carbapenems in pseudomonas aeruginosa
原文传递
导出
摘要 目的了解不同外排泵抑制剂(EPIs)在铜绿假单胞菌(PAE)对碳青霉烯类抗菌药物敏感性的影响。方法用琼脂对倍稀释法检测联合两种EPIs前后亚胺培南(IMP)、美罗培南(MER)的MIC值。结果 PAβN浓度为40μg/ml时能明显增强IMP、MER对PAE的敏感性;IMP、MER的敏感率分别由22.45%→77.55%,75.5ORP1%→91.84%;统计分析显示,差异有统计学意义(P<0.05);奥美拉唑(OMP)20μg/ml对碳青霉烯类抗菌药物敏感性影响较小。结论适当浓度的EPIs能增强碳青霉烯类抗菌药物对PAE的敏感性。 OBJECTIVE To study the effect of efflux pump inhibitors on carbapenems in Pseudornonas aeruginosa clinical isolates. METHODS The MICs of imipenem and meropenem with or without efflux pump inhibitors (EPIs) against 49 isolates were determined by the agar dilution method. RESULTS At a concentration of 40μg/ml, PAI3N had obviously effects on carbapenems MICs. The rate of sensitivity of imipenem and meropenem increased from 22.45% to 77.55% and from 75.51% to 91.84%. Statistical analysis showed there were statistical significance (P〈0.05). Omeprazole at a concentration of 20μg/ml had fewer effects on carbapenems MICs. CONCLUSION EPIs at a suitable concentration can increase the sensitirity of carbapenems in P. aeruginosa clinical isolates.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第5期841-843,共3页 Chinese Journal of Nosocomiology
关键词 铜绿假单胞菌 耐药 奥美拉唑 泵抑制剂 碳青霉烯类抗菌药物 Pseudomonas aeruginos Drug resistance Omeprazole Efflux pump inhibitors Carbapenems
  • 相关文献

参考文献14

  • 1Coban AY, Ekinci B, Durpinar B, A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates[J]. Chemotherapy,2004,50(1) :22-26.
  • 2刘辽,杨云霞,万莉红.奥美拉唑对耐氧氟沙星的铜绿假单胞菌主动外排泵的抑制作用[J].华西药学杂志,2007,22(6):616-618. 被引量:9
  • 3Valdezate S, Vindel A, Echeita A, et al. Topiosomerse Ⅱ and IV quinolone resistance determining regions in Stenotrophomonas rnaltophilia clinical isolates with different levels of quinolone susceptibility[J]. Antimicrob Agents Chemother, 2002,46(3) :665 671.
  • 4Mamelli L, Amoros JP, Pages JM, et al. A phenylalanine arginine beta naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to maerolides [J]. Int J Antimicrob Agents, 2003, 22 (3) : 237 241.
  • 5Tibbetts RJ, Lin TL, Wu CC. Insertional mutation of marA vitiates inducible multiple antimicrobial resistance in Salmonella enteriea subsp, enterica serovar Choleraesuis[J]. Vet Microbiol, 2005,109 (3-4) : 267 274.
  • 6Ghisalberti D, Masi M, Pages JM, et al. Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes[J]. Biochem Biophys Res Commun,2005,328(4): 1113-1118.
  • 7Hasdemir UO, Chevalier J, Nordmann P, et al. Detection and prevalence of active drug efflux mechanism in various multidrug resistant Klebsiella pneumoniae strains from Tur- key[J]. J Clin Microbiol,2004,42(6) :2701 2706.
  • 8Chan YY, Tan TM, Ong YM, etal. BpeAB OprB, a multi- drug efflux pump in gurkholderia pseudomallei[J]. Antimi crob Agents Chemother,2004,48(4) :1128-1135.
  • 9Sanchez P, Le U, Martinez JL. The efflux pump inhibitor Phe Arg beta naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump[J]. J Antimicrob Chemother, 2003,51 (4) : 1042-1045.
  • 10Giske CG, BorOn C, Wretlind 13, et al. Meropenem suscepti- bility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA[J]. Clin Microbiol Infect, 2005, 11 (8) :662-669.

二级参考文献46

共引文献77

同被引文献112

  • 1耿大升,李舒音,肖纯凌,刘光焱,徐天策,李新鸣,孙冶.沈阳市某三甲医院呼吸重症监护室病原菌分布及其耐药性[J].中国微生态学杂志,2023,35(6):703-707. 被引量:7
  • 2Valenza G,Muller S,Schmitt C,et al.Evaluation of the VITEK 2AST-N111card for detection of extended-spectrum beta-lactamases(ESBLs)in Escherichia coli,Klebsiella pneumoniae,and Kleb-siella oxytoca compared to ESBL Etests and combination diskmethods[J].Eur J Clin Microbiol Infect Dis,2011,30(7):869-872.
  • 3Thiyagaraian S, Thirumalai K, Nirmala S,et al. Effect of curcu- min on lung resistance-related protein (LRP) in retinoblastoma cells[J]. Curr Eye Res,2009,34(10).-845-851.
  • 4Rodriguez-Martinez J M,Poirel L,Nordmann P. Molecular epide-miology and mechanisms of carbapenem resistance in Pseudomonasaeruginosa[_]\. Antimicrobial agents and chemotherapy, 2009,53(11):4783-4788.
  • 5El Garch F, Bogaerts P, Bebrone Cyet al. OXA-198, an ac-quired carbapenem-hydrolyzing class D p-lactamase fromPseudomonas aeruginosa [J]. Antimicrobial agents and chem-otherapy .2011 ,55(10):4828-4833.
  • 6Zavascki AP. Carvalhaes CG, Picao RC, et al. Multidrug-re-sistant Pseudomonas aeruginosa and Acinetobacter bauman-nii {resistance mechanisms and implications for therapy[J].Expert review of anti-infective therapy,2010,8(1) :71-93.
  • 7Cuzon G,Naas T,Villegas MV,et al. Wide dissemination ofPseudomonas aeruginosa producing p-lactamase blaKPC-2gene in Colombia[J]. Antimicrobial agents and chemothera-py ,2011,55(11) : 5350*5353.
  • 8Cholley P,Gbaguidi-Haore H,Bertrand X. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital[J].Journal of Hospital Infection,2010,(04):316-319.
  • 9Zhao WH,Hu ZQ. beta-Lactamases identified in clinical isolates of[J].Critical Reviews in Microbiology,2010,(03):245-258.
  • 10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing,18th informational supplement[S].CLSI,2010.

引证文献12

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部